A detailed history of Spirepoint Private Client, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Spirepoint Private Client, LLC holds 7,986 shares of ABT stock, worth $912,240. This represents 0.12% of its overall portfolio holdings.

Number of Shares
7,986
Previous 8,163 2.17%
Holding current value
$912,240
Previous $848 Million 7.34%
% of portfolio
0.12%
Previous 0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$100.07 - $118.13 $17,712 - $20,909
-177 Reduced 2.17%
7,986 $910 Million
Q2 2024

Aug 08, 2024

SELL
$100.73 - $112.44 $18,433 - $20,576
-183 Reduced 2.19%
8,163 $848 Million
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $914,053 - $1.01 Million
8,346 New
8,346 $949 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Spirepoint Private Client, LLC Portfolio

Follow Spirepoint Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spirepoint Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spirepoint Private Client, LLC with notifications on news.